ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49209
0.00%
Bitcoin
66,945.10
-0.20%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Erytech Pharma SA (ERYP)

  7. Erytech Pharma SA (ERYP) News

ERYP

Erytech Pharma (ERYP)

Erytech Pharma SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ERYP
DateTimeSourceHeadlineSymbolCompany
01/07/202301:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ERYPErytech Pharma SA
30/06/202305:53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ERYPErytech Pharma SA
30/06/202305:52Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ERYPErytech Pharma SA
28/06/202322:54Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
28/06/202322:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ERYPErytech Pharma SA
21/06/202320:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
13/06/202300:34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
25/05/202306:52Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:ERYPErytech Pharma SA
24/05/202322:26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
17/05/202300:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
10/05/202300:30AllPennyStocks.comMicro Cap Bid Up Right Before Opening BellNASDAQ:ERYPErytech Pharma SA
18/04/202322:21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
24/03/202300:38Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
15/02/202304:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
14/02/202322:13Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
24/12/202209:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
23/11/202203:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
14/10/202221:12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
26/08/202203:21Dow Jones NewsErytech Pharma Shares Hit 52-Week Low After Ending Plans for License Application for GraspaNASDAQ:ERYPErytech Pharma SA
26/08/202200:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
28/06/202223:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
14/05/202201:37Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
02/05/202223:48Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
28/04/202222:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
28/04/202202:51Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ERYPErytech Pharma SA
26/04/202206:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
16/03/202200:20Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
15/02/202222:30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ERYPErytech Pharma SA
15/02/202205:49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
11/02/202200:26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
 Showing the most relevant articles for your search:NASDAQ:ERYP

Your Recent History

LSE
80GG
Hsbc Bk 31
POLO
SOVUSDT
ShibOriginalVision
LSE
WAS1
Wasps 22
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved